GabapentinMyoclonus in patients with end-stage renal disease: 3 case reports

被引:0
|
作者
机构
关键词
Public Health; Renal Disease; Gabapentin; Normal Activity; Dosage Increase;
D O I
10.2165/00128415-200510520-00033
中图分类号
学科分类号
摘要
引用
收藏
页码:10 / 10
相关论文
共 50 条
  • [4] HBV infection in patients with end-stage renal disease
    Fabrizi, F
    Bunnapradist, S
    Martin, P
    SEMINARS IN LIVER DISEASE, 2004, 24 : 63 - 70
  • [7] Implanted renal replacement for end-stage renal disease
    Roy, S.
    Goldman, K. G.
    Marchant, R. E.
    Zydney, A. L.
    Brown, D. L.
    Fleischman, A. J.
    Conlisk, A. T.
    Desai, T. A.
    Duffy, S.
    Humes, H. D.
    Fissell, W. H.
    PANMINERVA MEDICA, 2011, 53 (03) : 155 - 166
  • [8] Management of pain in end-stage renal disease patients: Short review
    Raina, Rupesh
    Krishnappa, Vinod
    Gupta, Mona
    HEMODIALYSIS INTERNATIONAL, 2018, 22 (03) : 290 - 296
  • [9] The impact of epilepsy and its treatment in patients with end-stage renal disease
    Leon, Silvia J.
    Tangri, Navdeep
    KIDNEY INTERNATIONAL, 2019, 96 (05) : 1063 - 1065
  • [10] Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients
    Moldovan, Diana
    Kacso, Ina Maria
    Rusu, Crina
    Potra, Alina
    Bondor, Cosmina Ioana
    Moldovan, Ioan
    Patiu, Ioan Mihai
    Vladutiu, Dan
    Caprioara, Mirela Gherman
    BIOMARKERS, 2015, 20 (02) : 116 - 122